Pedimune in recurrent respiratory infection and diarrhoea--the Indian experience--the pride study

Kamlesh Patel1, Rajiv Rana

  • 1Merck Ltd, Mumbai, India.

Insights

Bovine colostrum significantly reduced recurrent upper respiratory tract infections (URTIs) and diarrhea in children. This natural supplement also lowered hospitalization rates, demonstrating its effectiveness in improving children's health.

Area of Science:

  • Pediatrics
  • Immunology
  • Gastroenterology

Background:

  • Recurrent upper respiratory tract infections (URTIs) and diarrhea pose significant health challenges in children.
  • Prophylactic strategies are crucial for managing frequent infections and improving pediatric well-being.

Purpose of the Study:

  • To assess the efficacy and tolerability of bovine colostrum for preventing recurrent URTIs and diarrhea in children.
  • To evaluate the impact of bovine colostrum on hospitalization rates and overall health status.

Main Methods:

  • A 12-week study involving 605 children (aged 1-8 years) with recurrent URTIs or diarrhea.
  • Participants received bovine colostrum (Pedimune), with assessments of infection episodes, hospitalization, well-being, and adverse events every 4 weeks.

Main Results:

  • Significant reductions in URTI episodes (91.19%) and diarrhea (86.60%) were observed post-therapy.
  • Pediatricians reported high to average improvement in overall well-being for 96% of patients.
  • Patients/caretakers rated overall well-being as very good to good in 90.56% of cases.

Conclusions:

  • Bovine colostrum is highly effective for the prophylactic treatment of recurrent URTIs and diarrhea in children.
  • The use of bovine colostrum led to a notable decrease in infection episodes and related hospitalizations.
Abstract